MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 75 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $417,000 | +10.0% | 164,091 | -12.1% | 0.00% | – |
| Q1 2020 | $379,000 | -21.5% | 186,693 | -16.5% | 0.00% | – |
| Q4 2019 | $483,000 | +29.8% | 223,559 | -7.5% | 0.00% | – |
| Q3 2019 | $372,000 | -58.6% | 241,557 | +11.7% | 0.00% | – |
| Q2 2019 | $898,000 | +413.1% | 216,278 | +415.3% | 0.00% | – |
| Q1 2019 | $175,000 | +45.8% | 41,971 | 0.0% | 0.00% | – |
| Q4 2018 | $120,000 | -77.9% | 41,971 | -22.9% | 0.00% | – |
| Q3 2018 | $544,000 | +837.9% | 54,418 | +260.4% | 0.00% | – |
| Q1 2018 | $58,000 | -52.8% | 15,100 | 0.0% | 0.00% | – |
| Q4 2017 | $123,000 | +38.2% | 15,100 | 0.0% | 0.00% | – |
| Q3 2017 | $89,000 | – | 15,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |